LENZ Therapeutics (LENZ) Capital Expenditures (2020 - 2026)
LENZ Therapeutics (LENZ) reported Capital Expenditures of $18000.0 for Q1 2026, down 83.64% year-over-year from $110000.0 in Q1 2025, and down 52.63% quarter-over-quarter from $38000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Capital Expenditures (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Capital Expenditures data on file, last reported at $18000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $18000.0, down 83.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $735000.0 (up 134.82% YoY), and the FY2025 annual result was $827000.0, up 307.39% from the prior year.
- Capital Expenditures eased to $18000.0 in Q1 2026 per LENZ's latest filing, from $38000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.3 million in Q1 2022 and troughed at -$101000.0 in Q3 2024.
- A 5-year average of $548000.0 and a median of $152000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 809.17% in 2022, then slumped 99.82% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $1.0 million in 2022, then slumped by 97.65% to $24000.0 in 2023, then soared by 612.5% to $171000.0 in 2024, then slumped by 77.78% to $38000.0 in 2025, then slumped by 52.63% to $18000.0 in 2026.
- Business Quant data shows LENZ's Capital Expenditures at $18000.0 in Q1 2026, $38000.0 in Q4 2025, and $439000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 439,000.00 |
| Sep 30, 2025 | 439,000.00 |
| Jun 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 240,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Jun 30, 2024 | 133,000.00 |
| Jun 30, 2024 | 133,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |